European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation Technology
Portfolio Pulse from
IceCure Medical Ltd. has received an Intention to Grant Notice from the European Patent Office for its XSense™ system's cryogenic connector technology, which aims to enhance safety and maintain cryogen integrity in cryoablation procedures.
January 03, 2025 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IceCure Medical Ltd. has been granted an Intention to Grant Notice by the European Patent Office for its XSense™ cryogenic connector technology, which could enhance the safety and effectiveness of its cryoablation procedures.
The Intention to Grant Notice from the European Patent Office is a significant milestone for IceCure Medical, as it validates the innovation of their XSense™ technology. This could lead to increased adoption and market expansion in Europe, positively impacting the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100